References
Kargar M, Ahmadvand A, Gholami K. Comment on: “Adverse drug reaction-related hospitalizations in elderly Australians: a prospective cross-sectional study in two Tasmanian hospitals”. Drug Saf. 2017. https://doi.org/10.1007/s40264-017-0612-4.
Parameswaran Nair N, Chalmers L, Bereznicki BJ, Curtain C, Peterson GM, Connolly M, et al. Adverse drug reaction-related hospitalizations in elderly Australians: a prospective cross-sectional study in two Tasmanian Hospitals. Drug Saf. 2017;40(7):597–606.
Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30(2):239–45.
Seger D, Barker K, McNaughton C. Misuse of the Naranjo adverse drug reaction probability scale in toxicology. Clin Toxicol (Phila). 2013 Jul;51(6):461–6.
Parameswaran Nair N, Chalmers L, Connolly M, Bereznicki BJ, Peterson GM, Curtain C, et al. Prediction of hospitalization due to adverse drug reactions in elderly community-dwelling patients (The PADR-EC Score). PLoS One. 2016;11(10):e0165757.
Rawlins MD, Thompson JW. Mechanisms of adverse drug reactions. In: Davies DM, editor. Textbook of adverse drug reactions. Oxford: Oxford University Press; 1991. p. 18–45.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Funding
No sources of funding were used to assist in the preparation of this letter.
Conflict of interest
Luke R. Bereznicki reports personal fees from Boehringer Ingelheim Pty Ltd, outside the submitted work. Nibu Parameswaran Nair, Leanne Chalmers, Bonnie J. Bereznicki, Colin Curtain, Gregory M. Peterson, and Michael Connolly declare that they have no conflict of interest that are directly relevant to the content of this study.
Rights and permissions
About this article
Cite this article
Parameswaran Nair, N., Chalmers, L., Bereznicki, B.J. et al. Authors’ Reply to Mona Kargar and Colleagues’ Comment on “Adverse Drug Reaction-Related Hospitalizations in Elderly Australians: A Prospective Cross-Sectional Study in Two Tasmanian Hospitals”. Drug Saf 41, 323–324 (2018). https://doi.org/10.1007/s40264-017-0613-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40264-017-0613-3